Prof. Sam Muchina Kinyanjui
Director - IDeAL & Head Of Training
Collaborations
Videos
Bio
Sam started his research career in 1994 at the Wellcome Trust Labs in Nairobi doing malaria pharmacology studies and subsequently moved to Kilifi to study immunity to malaria as part of his PhD. In 2004, Sam was awarded a Wellcome Trust training fellowship. During the fellowship Sam also developed interest for capacity building for research and eventually in 2008 took up a post as the Head of Training and Capacity Building at the Programme. Sam’s roles include administering training activities and developing strategies for capacity building at the Programme and within the East African region as head of training at the KEMRI-Wellcome Trust Research Programme in Kenya.
See moreCurrent Work
Since 2008, Dr Samson Kinyanjui has overseen rapid growth in support for young African scientists. His vision extends further, though, as he hopes to help establish research networks to encourage scientists across Africa and build the continent’s future research capacity.
Recent publications
A retrospective analysis of P. falciparum drug resistance markers detects an early (2016/17) high prevalence of the k13 C469Y mutation in asymptomatic infections in Northern Uganda.
Ogwang, R., Osoti, V., Wamae, K., Ndwiga, L., Muteru, K., Ningwa, A., Tuju, J., Kinyanjui, S., Osier, F., Marsh, K., Bejon, P., Idro, R., Ochola-Oyier, L. I.
Antimicrob Agents Chemother, (2024). :e0157623
Antibodies to PfEMP1 and Variant Surface Antigens: Protection after Controlled Human Malaria Infection in Semi-immune Kenyan Adults.
Kinyua, A. W., Turner, L., Kimingi, H. W., Mwai, K., Mwikali, K., Andisi, C., Sim, B. K. L., Bejon, P., Kapulu, M. C., Kinyanjui, S. M., Lavstsen, T., Abdi, A. I.
J Infect, (2024). :106252
A scoping review of ethics review processes during public health emergencies in Africa.
Orievulu, K., Hinga, A., Nkosi, B., Ngwenya, N., Seeley, J., Akanlu, A., Tindana, P., Molyneux, S., Kinyanjui, S., Kamuya, D.
BMC Med Ethics, (2024). 25:63
Bi-isotype immunoglobulins enhance antibody-mediated neutrophil activity against Plasmodium falciparum parasites.
Ogwang, R., Murugu, L., Nkumama, I. N., Nyamako, L., Kai, O., Mwai, K., Murungi, L., Idro, R., Bejon, P., Tuju, J., Kinyanjui, S. M., Osier, F. H. A.
Front Immunol, (2024). 15:1360220
Designing and delivering bioinformatics project-based learning in East Africa.
Kibet, C. K., Entfellner, J. D., Jjingo, D., de Villiers, E. P., de Villiers, S., Wambui, K., Kinyanjui, S., Masiga, D.
BMC Bioinformatics, (2024). 25:150
Prof. Sam Muchina Kinyanjui
Director - IDeAL & Head Of Training
Biography
Sam started his research career in 1994 at the Wellcome Trust Labs in Nairobi doing malaria pharmacology studies and subsequently moved to Kilifi to study immunity to malaria as part of his PhD. In 2004, Sam was awarded a Wellcome Trust training fellowship. During the fellowship Sam also developed interest for capacity building for research and eventually in 2008 took up a post as the Head of Training and Capacity Building at the Programme. Sam’s roles include administering training activities and developing strategies for capacity building at the Programme and within the East African region as head of training at the KEMRI-Wellcome Trust Research Programme in Kenya.
See moreCurrent Work
Since 2008, Dr Samson Kinyanjui has overseen rapid growth in support for young African scientists. His vision extends further, though, as he hopes to help establish research networks to encourage scientists across Africa and build the continent’s future research capacity.
Collaborations
Project Research
No active details yet
Videos
A retrospective analysis of P. falciparum drug resistance markers detects an early (2016/17) high prevalence of the k13 C469Y mutation in asymptomatic infections in Northern Uganda.
Ogwang, R., Osoti, V., Wamae, K., Ndwiga, L., Muteru, K., Ningwa, A., Tuju, J., Kinyanjui, S., Osier, F., Marsh, K., Bejon, P., Idro, R., Ochola-Oyier, L. I.
Antimicrob Agents Chemother, (2024). :e0157623
Antibodies to PfEMP1 and Variant Surface Antigens: Protection after Controlled Human Malaria Infection in Semi-immune Kenyan Adults.
Kinyua, A. W., Turner, L., Kimingi, H. W., Mwai, K., Mwikali, K., Andisi, C., Sim, B. K. L., Bejon, P., Kapulu, M. C., Kinyanjui, S. M., Lavstsen, T., Abdi, A. I.
J Infect, (2024). :106252
A scoping review of ethics review processes during public health emergencies in Africa.
Orievulu, K., Hinga, A., Nkosi, B., Ngwenya, N., Seeley, J., Akanlu, A., Tindana, P., Molyneux, S., Kinyanjui, S., Kamuya, D.
BMC Med Ethics, (2024). 25:63
Bi-isotype immunoglobulins enhance antibody-mediated neutrophil activity against Plasmodium falciparum parasites.
Ogwang, R., Murugu, L., Nkumama, I. N., Nyamako, L., Kai, O., Mwai, K., Murungi, L., Idro, R., Bejon, P., Tuju, J., Kinyanjui, S. M., Osier, F. H. A.
Front Immunol, (2024). 15:1360220
Designing and delivering bioinformatics project-based learning in East Africa.
Kibet, C. K., Entfellner, J. D., Jjingo, D., de Villiers, E. P., de Villiers, S., Wambui, K., Kinyanjui, S., Masiga, D.
BMC Bioinformatics, (2024). 25:150
Prof. Sam Muchina Kinyanjui 9
Director - IDeAL & Head Of Training
Biography
Sam started his research career in 1994 at the Wellcome Trust Labs in Nairobi doing malaria pharmacology studies and subsequently moved to Kilifi to study immunity to malaria as part of his PhD. In 2004, Sam was awarded a Wellcome Trust training fellowship. During the fellowship Sam also developed interest for capacity building for research and eventually in 2008 took up a post as the Head of Training and Capacity Building at the Programme. Sam’s roles include administering training activities and developing strategies for capacity building at the Programme and within the East African region as head of training at the KEMRI-Wellcome Trust Research Programme in Kenya.